Cabot Corporation (CBT) vs Calumet, Inc. (CLMT)
Cabot Corporation and Calumet, Inc. are both Specialty Chemicals companies. Calumet, Inc. is the larger, with a market value of $4.7B against $4.1B — 1.2× the size. Calumet, Inc. has negative trailing earnings, so its P/E is not meaningful; Cabot Corporation trades at 22.1×. Calumet, Inc. grew revenue faster over the last twelve months: 12.8% against −4.74%. Cabot Corporation has the higher net margin (5.28% vs −2.98%) and the higher return on invested capital (11.2% vs 2.03%). Across the 19 metrics below, Cabot Corporation leads on 13 and Calumet, Inc. on 6.
Valuation
Profitability
| Metric | CBT | CLMT | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 22.70% | 6.57% | 29.23% |
| Operating margin | 13.57% | 1.03% | 3.63% |
| Net margin | 5.28% | (2.98%) | 2.89% |
| Free cash flow margin | 8.48% | 1.60% | 3.78% |
| Return on equity | 11.24% | 12.74% | 3.62% |
| Return on assets | 4.92% | (4.90%) | 0.35% |
| Return on invested capital | 11.18% | 2.03% | 2.75% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack